Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

3(75.0%)

Phase 3

1(25.0%)

4Total

N/A(3)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT02628457Unknown

Did MRI Appearance of Supraspinatus Muscle Atrophy Changes After Repair of All Kind of Rotator Cuff Tear?

Role: lead

NCT01996904Not ApplicableCompleted

Prospective Randomized Comparative Study of Outcome of Subscapularis Tear

Role: lead

NCT02052089Not ApplicableCompleted

Comparative Study for the Optimal Treatment Method of Lateral Epicondylosis

Role: lead

NCT01992627Not ApplicableUnknown

Clinical Trial for High Intensity Laser Therapy (HILT) for Elbow Epicondylosis

Role: lead

NCT01984931Phase 3Unknown

Study of Trimebutine Maleate (NEWBUTIN SR 300 mg Tab)for Treatment of Post Operative Nausea and Vomiting

Role: lead

All 5 trials loaded